784.84澳幣0.62(0.08%)
2024/09/27更新
績效 / 1月4.85%
3月2.07%
1年21.91%
晨星評等-
- 1.現金1.42%
- 2.股票8.97%
- 3.債券0.05%
- 4.其他89.56%
- 1.美國89.56%
- 2.歐元區2.89%
- 3.歐洲不包含歐元區2.71%
- 4.英國1.69%
- 5.加拿大1.68%
- 1.Regeneron Pharmaceuticals Inc6.00%
- 2.argenx SE ADR5.31%
- 3.Gilead Sciences Inc4.13%
- 4.Biomarin Pharmaceutical Inc3.80%
- 5.Sarepta Therapeutics Inc3.73%
- 6.Vertex Pharmaceuticals Inc3.45%
- 7.Cytokinetics Inc3.27%
- 8.Intra-Cellular Therapies Inc3.26%
- 9.Zealand Pharma AS3.17%
- 10.Insmed Inc3.13%
- 1.現金1.42%
- 2.股票8.97%
- 3.債券0.05%
- 4.其他89.56%
- 1.美國89.56%
- 2.歐元區2.89%
- 3.歐洲不包含歐元區2.71%
- 4.英國1.69%
- 5.加拿大1.68%
- 1.Regeneron Pharmaceuticals Inc6.00%
- 2.argenx SE ADR5.31%
- 3.Gilead Sciences Inc4.13%
- 4.Biomarin Pharmaceutical Inc3.80%
- 5.Sarepta Therapeutics Inc3.73%
- 6.Vertex Pharmaceuticals Inc3.45%
- 7.Cytokinetics Inc3.27%
- 8.Intra-Cellular Therapies Inc3.26%
- 9.Zealand Pharma AS3.17%
- 10.Insmed Inc3.13%